These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38309089)

  • 1. Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART).
    Schmitz JM; Stotts AL; Vujanovic AA; Yoon JH; Webber HE; Lane SD; Weaver MF; Vincent J; Suchting R; Green CE
    Drug Alcohol Depend; 2024 Mar; 256():111078. PubMed ID: 38309089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual.
    Schmitz JM; Stotts AL; Vujanovic AA; Weaver MF; Yoon JH; Vincent J; Green CE
    Contemp Clin Trials; 2018 Feb; 65():109-115. PubMed ID: 29287664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.
    Schmitz JM; Green CE; Stotts AL; Lindsay JA; Rathnayaka NS; Grabowski J; Moeller FG
    Drug Alcohol Depend; 2014 Mar; 136():100-7. PubMed ID: 24424425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence.
    Morgan PT; Angarita GA; Canavan S; Pittman B; Oberleitner L; Malison RT; Mohsenin V; Hodges S; Easton C; McKee S; Bessette A; Forselius E
    Drug Alcohol Depend; 2016 Mar; 160():49-56. PubMed ID: 26777774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram for treatment of cocaine use disorder: A Bayesian drop-the-loser randomized clinical trial.
    Suchting R; Green CE; de Dios C; Vincent J; Moeller FG; Lane SD; Schmitz JM
    Drug Alcohol Depend; 2021 Nov; 228():109054. PubMed ID: 34600245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial.
    Ware OD; Sweeney MM; Cunningham C; Umbricht A; Stitzer M; Dunn KE
    JAMA Netw Open; 2023 Mar; 6(3):e232278. PubMed ID: 36920397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
    Tardelli VS; Bisaga A; Arcadepani FB; Gerra G; Levin FR; Fidalgo TM
    Psychopharmacology (Berl); 2020 Aug; 237(8):2233-2255. PubMed ID: 32601988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients.
    Petry NM; Barry D; Alessi SM; Rounsaville BJ; Carroll KM
    J Consult Clin Psychol; 2012 Apr; 80(2):276-85. PubMed ID: 22229758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial.
    Carpenter KM; Choi CJ; Basaraba C; Pavlicova M; Brooks DJ; Brezing CA; Bisaga A; Nunes EV; Mariani JJ; Levin FR
    Exp Clin Psychopharmacol; 2024 Feb; 32(1):112-127. PubMed ID: 37732961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of incorporating contingency management into a public treatment program for people who use crack cocaine in Brazil. A single-blind randomized controlled trial.
    Miguel AQC; McPherson SM; Simões V; Yamauchi R; Madruga CS; Smith CL; da Silva CJ; Laranjeira RR; McDonell MG; Roll JM; Mari JJ
    Int J Drug Policy; 2022 Jan; 99():103464. PubMed ID: 34619447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for Cocaine Use Disorder-a Systematic Review and Meta-analysis.
    Chan B; Kondo K; Freeman M; Ayers C; Montgomery J; Kansagara D
    J Gen Intern Med; 2019 Dec; 34(12):2858-2873. PubMed ID: 31183685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percentage of negative urine drug screens as a clinically meaningful endpoint for RCTs evaluating treatment for cocaine use.
    Loya JM; Babuscio TA; Nich C; Alessi SM; Rash C; Kiluk BD
    Drug Alcohol Depend; 2023 Jul; 248():109947. PubMed ID: 37276806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil for the treatment of cocaine dependence.
    Anderson AL; Reid MS; Li SH; Holmes T; Shemanski L; Slee A; Smith EV; Kahn R; Chiang N; Vocci F; Ciraulo D; Dackis C; Roache JD; Salloum IM; Somoza E; Urschel HC; Elkashef AM
    Drug Alcohol Depend; 2009 Sep; 104(1-2):133-9. PubMed ID: 19560290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cocaine demand following contingency management treatment.
    Yoon JH; Suchting R; de Dios C; Vincent JN; McKay SA; Lane SD; Schmitz JM
    Drug Alcohol Depend; 2021 Sep; 226():108883. PubMed ID: 34198136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modafinil Does Not Reduce Cocaine Use in Methadone-Maintained Individuals.
    DeVito EE; Poling J; Babuscio T; Nich C; Carroll KM; Sofuoglu M
    Drug Alcohol Depend Rep; 2022 Mar; 2():. PubMed ID: 36310662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment.
    Winhusen TM; Kropp F; Theobald J; Lewis DF
    Drug Alcohol Depend; 2014 Jan; 134():391-395. PubMed ID: 24128381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis.
    De Crescenzo F; Ciabattini M; D'Alò GL; De Giorgi R; Del Giovane C; Cassar C; Janiri L; Clark N; Ostacher MJ; Cipriani A
    PLoS Med; 2018 Dec; 15(12):e1002715. PubMed ID: 30586362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
    Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.
    Somoza EC; Winship D; Gorodetzky CW; Lewis D; Ciraulo DA; Galloway GP; Segal SD; Sheehan M; Roache JD; Bickel WK; Jasinski D; Watson DW; Miller SR; Somoza P; Winhusen T
    JAMA Psychiatry; 2013 Jun; 70(6):630-7. PubMed ID: 23575810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
    Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL
    Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.